SEC suggests Covid-19 immunization Corbevax for 12 to 18 year age group: Report Kumar Jeetendra | February 15, 2022 The Drugs Controller General of India (DCGI)’s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E’s COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions, official sources said. The country’s central drug authority is expected to give final approval to Corbevax, which is …
